Wall St closes higher as vaccine update feeds optimism



(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)

* Travel stocks advance after vaccine update

* Nasdaq in front; communications services lead sector gains

* Indexes up: Dow up 0.1%, S&P 500 up 0.31%, Nasdaq up 0.64%

By Caroline Valetkevitch and Sinéad Carew

NEW YORK, Dec 8 (Reuters) - Wall Street closed slightly higher on Wednesday with the three major indexes managing their third straight day of gains after test data showed the COVID-19 vaccine from Pfizer and BioNTech offered some protection against the new Omicron variant.

Pfizer PFE.N and BioNTech BNTX.O said their three-shot course of the vaccine was able to neutralize the Omicron variant in a laboratory test and they could deliver an upgraded vaccine in March 2022 if needed.

Investors reacted by piling into travel related stocks. The S&P 1500 Airlines index .SPCOMAIR closed up 1.96%. Its session high was the highest since Nov. 24, which was just before news of the variant emerged.

Markets have been hugely volatile since the variant was discovered, with investors worried Omicron could force new restrictions in countries and hurt the global recovery.

In a bid to slow its spread, Britain said Wednesday it could implement tougher measures, including advice to work from home, as early as Thursday.

While Pfizer said Omicron protection was reduced among people who took just two doses of the vaccine, investors were still somewhat reassured.

With Nasdaq outperforming the Dow, Paul Nolte, portfolio manager at Kingsview Investment Management in Chicago described the session as a "perfect risk-on kind of day."

"A lot is revolving around virus news. It's a reopening trade more than anything else," said Nolte.

The Dow Jones Industrial Average .DJI rose 35.32 points, or 0.1%, to 35,754.75, the S&P 500 .SPX gained 14.46 points, or 0.31%, to 4,701.21 and the Nasdaq Composite .IXIC added 100.07 points, or 0.64%, to 15,786.99.

The S&P finished less than a point below where it closed before a steep sell-off. The index fell as much as 4.4% between Nov. 24, the day before Thanksgiving, and Friday, as investors fled risky bets due to Omicron fears and concerns about rising interest rates after a Federal Reserve update last week.

"Equity investors are buying into the thesis that rates won't have to go up very much to tame inflation. It makes them more comfortable buying stocks although more inclined to buy quality growth stocks than cyclicals," said Jack Ablin, chief investment officer at Cresset Capital Management in Chicago.

Sector gains were led by communication services .SPLRCL , which rose 0.75% followed closely by healthcare .SPXHC , up 0.74%. With only three of the 11 major S&P sectors losing ground on the day, the laggards were financials .SPSY , down 0.46%, consumer staples .SPLRCS , down 0.37% and utilities .SPLRCU , which edged down 0.1%.

WHO director-general Tedros Adhanom Ghebreyesus said governments should urgently reassess their national responses to COVID-19 and accelerate their vaccination programs.

So-called reopening stocks, most affected by the pandemic's lockdowns, were among the S&P's top gainers on Wednesday. These included Norwegian Cruise Line NCLH.K , up 8%, Carnival Corp CCL.N , up 5.5% and Royal Caribbean RCL.N , up 5.2%.

Goodyear Tire & Rubber Co GT.O rose 2.6% after Deutsche Bank upgraded the stock to "buy" from "hold".

Stanley Black & Decker SWK.N advanced 3.3% after Sweden's Securitas SECUb.ST agreed to buy its electronic security solutions business for $3.2 billion.

Advancing issues outnumbered declining ones on the NYSE by a 1.68-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored advancers.

The S&P 500 posted 31 new 52-week highs and no new lows; the Nasdaq Composite recorded 36 new highs and 39 new lows.

On U.S. exchanges 10.3 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions.
Additional reporting by Devik Jain and Shreyashi Sanyal in Bengaluru; Editing by Maju Samuel and David Gregorio

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Ang iyong kapital ay maaaring malugi. Ang mga produktong naka-leverage ay maaaring hindi para sa lahat. Tingnan ang aming Risk Disclosure.